Abiopharma

Firefly Confirms Public-Private Partnership with the Department of War

Sypris Reports Fourth Quarter Results

Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update

Isracard report regarding the execution of a 10-year agreement for the issuance of branded FLY CARD credit cards, details

Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçets Disease

BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD

FORM 6-KBrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD

Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

Atara Biotherapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ATRA